BrainsWay is dedicated to developing and providing advanced technology solutions for the treatment of a variety of brain disorders. The company was established in 2003, and became a public company traded on the Tel-Aviv Stock Exchange in January 2007. This is an ADR of a company whose stock trades outside of the U.S. as the symbol IT:BRIN.
$8.45 +0.05 (0.60%)
As of 03/05/2021 16:00:00 EST IEX book CBOE book
2021 © Stock Market MBA, Inc.